Infographic | September 18, 2018

Approaches To CMC Involvement Across Drug Development

Source: ISR Reports
ISR Reports

In Q42017, ISR interviewed fifteen tenured CMC professionals at top 50 Pharma companies to learn when during the drug development cycle CMC has its greatest involvement and influence.  Two alternate approaches were relayed to ISR by research participants—in the first approach CMC’s greatest influence is early on and decreases as the compound matures. In the second approach, influence starts low and increases with each phase of development. 


Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Pharmaceutical Online? Subscribe today.

Subscribe to Pharmaceutical Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Pharmaceutical Online